Acne Spot Treatment Recalled Nationwide for Benzene Contamination
SLMD BP Acne Spot Treatment (10% Benzoyl Peroxide, 15 mL bottles) is recalled due to benzene contamination. The recall affects 2,269 bottles distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for benzene contamination in a topical product. No illnesses have been reported. Although benzene is a known hazardous chemical, the absence of reported harm and the Class II classification place this at High severity rather than Severe.
Plain-English summary
SLMD BP Acne Spot Treatment (10% Benzoyl Peroxide, 15 mL bottles) is being recalled due to the presence of benzene. The product is manufactured by Owen Biosciences Inc. and distributed by Skin PS Brands in Culver City, California.
The recall affects 2,269 bottles with two specific lot numbers: Lot# 2567200 (expiration 8/1/26) and Lot# 2691600 (expiration 10/30/2027). The affected product was distributed nationwide.
Benzene is a known hazardous chemical. Consumers who have purchased this product should verify their lot number and contact the distributor for guidance if their product matches one of the recalled lots.
The recalled product
- Product
- SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles, Sandra Lee MD, Distributed by Skin PS Brands, Culver City, CA90232.
- Manufacturer
- Owen Biosciences Inc.
- Category
- Drug — Topical Acne Treatment
- Hazard
- benzene
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 2567200
- Exp.8/1/26 Lot# 2691600
- Exp.10/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27